Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

or browse faculty by school:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

Reset
First Prev 1 2 3 4 5 6 7 8 9 10 Next Last

  • Abraham, W. T., Burkhoff, D., Nademanee, K., Carson, P., Bourge, R., Ellenbogen, K. A., . . . Kadish, A. H. (2008). A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale, design, and baseline patient characteristics. American Heart Journal, 156(4), 641-648.e1. This material can be found here.

  • Ahmed, M. W., Kadish, A. H., Parker, M. A., & Goldberger, J. J. (1994). Effect of physiologic and pharmacologic adrenergic stimulation on heart rate variability. Journal of the American College of Cardiology, 24(4), 1082-1090. This material can be found here.

  • Al-Khatib, S. M., Han, J. Y., Edwards, R., Bardy, G. H., Bigger, J. T., Buxton, A. E., . . . Kadish, A. H. (2014). Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? International Journal of Cardiology, 172(1), 253-254. doi:10.1016/j.ijcard.2013.12.278

    		•

  • Altura, B. M., Gebrewold, A., Shah, N. C., Shah, G. J., & Altura, B. T. (2016). Potential roles of magnesium deficiency in inflammation and atherogenesis: Importance and cross-talk of platelet-activating factor and ceramide. Journal of Clinical & Experimental Cardiology, 7 [Article 427]. doi:10.4172/2155-9880.1000427

    		•

  • Altura, B. M., Li, W., Zhang, A., Zheng, T., Shah, N. C., Shah, G. J., . . . Altura, B. T. (2016). Sudden cardiac death in infants, children and young adults: Possible roles of dietary magnesium intake and generation of platelet-activating factor in coronary arteries. Journal of Heart Health, 2(2). doi:10.16966/2379-769X.121

    		•

  • Altura, B. M., Li, W., Zhang, A., Zheng, T., Shah, N. C., Shah, G. J., . . . Altura, B. T. (2016). The expression of platelet-activating factor is induced by low extracellular Mg2+ in aortic, cerebral and neonatal coronary vascular smooth muscle; cross talk with ceramide production, NF–kB and proto-oncogenes: Possible links to atherogenesis and sudden cardiac death in children and infants, and aging: Hypothesis, review and viewpoint. International Journal of Cardiology and Research, 3(1), 47-67. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., & Altura, B. T. (2016). Genotoxic effects of magnesium deficiency in the cardiovascular system and their relationships to cardiovascular diseases and atherogenesis [Special issue]. Journal of Cardiovascular Diseases & Diagnosis, S1 [Article 008]. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., Pérez-Albela, J. L., & Altura, B. T. (2016). Insights into the possible mechanisms by which platelet-activating factor and PAF-receptors function in vascular smooth muscle in magnesium deficiency and vascular remodeling: Possible links to atherogenesis, hypertension and cardiac failure. International Journal of Cardiology and Research, 3(1e), 1-3. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., Pérez-Albela, J. L., & Altura, B. T. (2016). Magnesium deficiency results in oxidation and fragmentation of DNA, down regulation of telomerase activity, and ceramide release in cardiovascular tissues and cells: Potential relationship to atherogenesis, cardiovascular diseases and aging. International Journal of Diabetology & Vascular Disease Research, 4(1e), 1-5. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., Perez-Albela, J. L., & Altura, B. T. (2016). Why is postoperative atrial fibrillation difficult to prevent and treat: Potential roles of unrecognized magnesium deficiency and release of ceramide and platelet-activating factor. International Journal of Surgery and Research, 3(3), 47-51. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., Zhang, A., Li, W., & Altura, B. T. (2016). Is the high frequency of postoperative atrial fibrillation after cardiac and lung surgeries related to hypomagnesemia and releases of ceramides and platelet-activating factor? Clinics in Surgery, 1 [Article 1140]. This material can be found here.

  • Amar, D., Zhang, H., Miodownik, S., & Kadish, A. H. (2003). Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. Journal of the American College of Cardiology, 42(7), 1262-1268. doi:10.1016/S0735-1097(03)00955-0

    		•

  • Amar, S., Wu, S. C., & Madan, M. (2009). Is porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. Journal of Immunology, 182(3), 1584-1592. This material can be found here.

  • Arora, R., Ulphani, J. S., Villuendas, R., Ng, J., Harvey, L., Thordson, S., . . . Kadish, A. H. (2008). Neural substrate for atrial fibrillation: Implications for targeted parasympathetic blockade in the posterior left atrium. American Journal of Physiology: Heart & Circulatory Physiology, 294(1), H134-144. doi:10.1152/ajpheart.00732.2007

    		•

  • Arora, R., Villuendas, R., Ng, J., Goldstein, J., Mottl, S., Goldberger, J. J., . . . Kadish, A. H. (2007). Targeted G-protein inhibition in the posterior left atrium: A novel method to selectively inhibit parasympathetic signaling in the left atrium [Supplemental material]. Heart Rhythm, 4(5), S9-S10.

  • Ayzman, I., Dibs, S., Goldberger, J. J., Passman, R., & Kadish, A. H. (2002). In vitro performance characteristics of reused ablation catheters. Journal of Interventional Cardiac Electrophysiology, 7(1), 53-59. doi:10.1023/A:1020820200112

    		•

  • Bansal, N., Szpiro, A., Masoudi, F., Greenlee, R. T., Smith, D. H., Magid, D. J., . . . Kadish, A. H. (2017). Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart, 103(7), 529-537. This material can be found here.

  • Banthia, S., Bergner, D. W., Chicos, A. B. , Ng, J., Pelchovitz, D. J., Subacius, H., . . . Kadish, A. H. (2013). Detection of cardiovascular autonomic neuropathy using exercise testing in patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 27(1), 64–69. doi: 10.1016/j.jdiacomp.2012.09.002

    		•

  • Bello, D., Kaushal, R., Fieno, D. S., Goldberger, J. J., Shivkumar, K., & Kadish, A. H. (2005). Cardiac MRI: Detection of myocardial infarction in symptomatic patients without coronary artery disease undergoing electrophysiological testing [Supplemental material]. Heart Rhythm, 2(5), S148. doi:10.1016/j.hrthm.2005.02.464

    		•

  • Belperio, J., Horwich, T., Abraham, W. T., Fonarow, G. C., Gorcsan, J., III, Bersohn, M. M., . . . Kadish, A. H. (2016). Inflammatory mediators and clinical outcome in patients with advanced heart failure receiving cardiac resynchronization therapy. American Journal of Cardiology, 117(4), 617-625. doi:10.1016/j.amjcard.2015.11.049

    		•

  • Bennett, W., Lombardi, D., Eisenhart, A., Acosta, J., Cerbone, D., McCoy, L., & Yens, D. P. (2008). Risk factors for acute myocardial infarction in our patient population: A retrospective pilot study. New York Medical Journal, 3(2). This material can be found here.

  • Bergeron, N., Phan, B. A., Ding, Y., Fong, A., & Krauss, R. M. (2015). Proprotein convertase subtilisin/kexin type 9 inhibition: A new therapeutic mechanism for reducing cardiovascular disease risk. Circulation, 132(17), 1648-1666. doi:10.1161/CIRCULATIONAHA.115.016080

    		•

  • Boekholdt, S. M., Arsenault, B. J., Hovingh, G. K., Mora, S., Pedersen, T. R., LaRosa, J. C., . . . Clearfield, M. (2013). Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: A meta-analysis. Circulation, 128(14), 1504-1512.  doi:10.1161/CIRCULATIONAHA.113.002670

    		•

  • Boekholdt, S. M., Arsenault, B. J., Mora, S., Pedersen, T. R., LaRosa, J. C., Nestel, P. J., . . . Clearfield, M. B. (2012). Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: A meta-analysis. JAMA, 307(12), 1302-1309. doi:10.1001/jama.2012.366

    		•

  • Boekholdt, S. M., Hovingh, G. K., Mora, S., Arsenault, B. J., Amarenco, P., Pedersen, T. R., . . . Clearfield, M. B. (2014). Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials. Journal of the American College of Cardiology, 64(5), 485-494. doi:10.1016/j.jacc.2014.02.615

    		•
First Prev 1 2 3 4 5 6 7 8 9 10 Next Last